The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars.
The typical case for the fund is to invest in rounds with 5-6 participants. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Visionary Venture Fund, Versant Ventures.
Among the most popular portfolio startups of the fund, we may highlight Metavention. Among the most popular fund investment industries, there are Diabetes, Biotechnology. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Related Funds
Fund Name | Location |
Anomaly Ventures | - |
BENE Asia Capital | - |
Carmenta Capital Management | Alameda, California, United States |
Farmington Capital Partners | Connecticut, Hartford, United States |
Jerusalem Capital | Israel, Jerusalem, Jerusalem District |
Liuhang Juntong | Beijing, Beijing, China |
Mesoblast | Australia, Melbourne, Victoria |
Montpelier Re Holdings | Bermuda, Hamilton |
Parthenon Capital Partners | Boston, Massachusetts, United States |
Paytm | India, Noida, Uttar Pradesh |
Sansiri | - |
Sherpalo Ventures | California, Menlo Park, United States |
Spencer Trask & Co. | Connecticut, Greenwich, United States |
Suzhou Gaomei Capital | China, Jiangsu, Suzhou |
Suzhou Zhanyi Investment | China, Jiangsu, Suzhou |
TRW Automotive Holdings | Livonia, Michigan, United States |
WatchGuard | Seattle, United States, Washington |
WizEvo | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Vibrato Medical | $4M | 14 Sep 2021 | Newport Beach, California, United States | ||
Tarsus Pharmaceuticals | $60M | 08 Jan 2020 | Irvine, California, United States | ||
Metavention | $65M | 08 Jan 2018 | Minnesota, United States | ||
$23M | 07 Oct 2014 | Boston, Massachusetts, United States |
– Vibrato Medical has closed a $4M Series A funding round led by the Horowitz Group, a multi-asset class family investment office based in Newport Beach, CA.
– The company has also received a $1.5M NIH grant.
– This funding will support the clinical trial of the company’s novel, noninvasive, wearable device designed to treat patients with critical limb ischemia (CLI), an advanced stage of peripheral arterial disease (PAD).
– The therapeutic ultrasound has shown to promote vasodilation and long-term blood vessel growth in weeks and is appropriate for daily treatments.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Vibrato Medical | $4M | 14 Sep 2021 | Newport Beach, California, United States | ||
Tarsus Pharmaceuticals | $60M | 08 Jan 2020 | Irvine, California, United States | ||
Metavention | $65M | 08 Jan 2018 | Minnesota, United States | ||
$23M | 07 Oct 2014 | Boston, Massachusetts, United States |